Related Experiment Video
Updated: Jun 11, 2025

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
How Protein Depletion Balances Thrombosis and Bleeding Risk in the Context of Platelet's Activatory and Negative
Hector Montecino-Garrido1, Andrés Trostchansky2, Yolanda Espinosa-Parrilla3
1Centro de Estudios en Alimentos Procesados (CEAP), ANID-Regional, Gore Maule R0912001, Talca 3480094, Chile.
Platelets regulate bleeding and clotting through balanced activatory and negative signaling pathways. Understanding this balance is key to developing therapies for bleeding disorders and thrombotic events.
Area of Science:
- Hematology
- Molecular Biology
- Biochemistry
Background:
- Platelets are critical cell fragments for hemostasis, necessitating precise regulation of signaling pathways.
- A balance between activatory and negative signaling pathways in platelets is essential for normal function.
- Dysregulation of these pathways can lead to severe bleeding or thrombotic events.
Purpose of the Study:
- To emphasize the importance of the balance between platelet activatory and negative signaling pathways.
- To highlight the limitations of studying individual proteins or metabolites in isolation.
- To underscore the therapeutic potential of understanding and modulating this signaling balance.
Main Methods:
- Review and synthesis of existing knowledge on platelet signaling pathways.
- Analysis of the roles of activatory and negative signaling mediators.
- Conceptual framework for understanding pathway dysregulation and its consequences.
Main Results:
- Activatory signaling enhances platelet responses to stimuli.
- Negative signaling controls and dampens platelet responses, preventing thrombosis.
- Imbalances result in pathological conditions like bleeding or clotting disorders.
Conclusions:
- Studying platelet signaling in isolation is insufficient for comprehensive understanding.
- The balance between activatory and negative signaling is crucial for hemostasis.
- Targeting this balance offers a promising strategy for treating bleeding and thrombotic disorders.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis